4.8 Review

MicroRNA-206: a Promising Theranostic Marker

Journal

THERANOSTICS
Volume 4, Issue 2, Pages 119-133

Publisher

IVYSPRING INT PUBL
DOI: 10.7150/thno.7552

Keywords

microRNA-206; Theranostic Marker

Funding

  1. European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]
  2. [MUNI/A/0951/2012]

Ask authors/readers for more resources

MicroRNAs (miRs) are small non-coding RNAs that negatively regulate gene expression by binding to the 3 ' untranslated regions (3 ' UTR) of their target mRNAs. MiRs were shown to play pivotal roles in tissue development and function and are also involved in the pathogenesis of various diseases including cancer. MicroRNA-206, which belongs to the group of so-called myomiRs, is one of the most studied miRs thus far. In addition to being involved in skeletal muscle development and pathology, it has also been established that it is involved in the pathogenesis of numerous diseases including heart failure, chronic obstructive pulmonary disease, Alzheimer's disease and various types of cancers. The aim of this review is to provide a complex overview of microRNA-206, including regulating its expression, a brief description of its known functions in skeletal muscle and a complex overview of its roles in the biology and pathology of other tissues, emphasizing its significant diagnostic and therapeutic potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available